Cargando…
SET Domain Containing 2 Deficiency in Myelodysplastic Syndrome
Recent studies have shown that myelodysplastic syndrome’s (MDS) progression to acute myeloid leukemia (AML) is associated with gene mutations. SET domain containing 2 (SETD2) variants were reported as a risk factor of poor prognosis in patients with AML. However, little is known about the potential...
Autores principales: | Li, Jiaming, Peng, Zhenping, Luo, Fangxiu, Chen, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423969/ https://www.ncbi.nlm.nih.gov/pubmed/32849799 http://dx.doi.org/10.3389/fgene.2020.00794 |
Ejemplares similares
-
Predicting leukemic transformation in myelodysplastic syndrome using a transcriptomic signature
por: Guo, Chao, et al.
Publicado: (2023) -
Bioinformatics gene analysis of potential biomarkers and therapeutic targets of osteoarthritis associated myelodysplastic syndrome
por: Xin, Peicheng, et al.
Publicado: (2023) -
Myelodysplastic Syndrome-Associated SRSF2 Mutations Cause Splicing Changes by Altering Binding Motif Sequences
por: Masaki, So, et al.
Publicado: (2019) -
Decitabine Induces Change of Biological Traits in Myelodysplastic Syndromes via FOXO1 Activation
por: Zhang, Zheng, et al.
Publicado: (2021) -
Copper Deficiency Mimicking Myelodysplastic Syndrome: Zinc Supplementation in the Setting of COVID-19
por: Rosenberg, Maya, et al.
Publicado: (2023)